✦ LIBER ✦

Continuous infusion of methotrexate in children with acute leukemia

✍ Scribed by Isaac Djerassi; Sidney Farber; Esshagh Abir; William Neikirk

Publisher: John Wiley and Sons
Year: 1967
Tongue: English
Weight: 732 KB
Volume: 20
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(1967)20:2<233::aid-cncr2820200209>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continuous infusion mitoxantrone in rela

Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia

✍ Lynne S. Kaminer; Kyung E. Choi; Karen M. Daley; Richard A. Larson 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 2 views

Mitoxantrone is a substituted anthraquinone with considerable activity against human acute leukemia. The authors' goal was to treat patients with continuous infusion mitoxantrone in order to maintain cytotoxic steady state levels with acceptable toxicity and to assess the results. Daily mitoxantrone

Randomized comparison of moderate-dose m

Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: A Childrens Cancer Group study

✍ Lange, Beverly J.; Blatt, Julie; Sather, Harland N.; Meadows, Anna T. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

Methotrexate (MTX) infusions of 500-1,000 mg/m2 over 24 hours may improve survival and prevent relapse in children with acute lymphoblastic leukemia (ALL). Childrens Cancer Group (CCG) Study 139 compared weekly oral methotrexate 20 mg/m2/ week (oral MTX) to MTX 500 mg/m2 infused over 24 hours (IV MT

Methotrexate infusions in poor prognosis

Methotrexate infusions in poor prognosis acute lymphoblastic leukemia in children: I. The Norwegian methotrexate study in acute lymphoblastic leukemia in childhood, august 1975-December 1980

✍ Moe, Peter Johan ;Seip, Martin ;Finne, Per H. ;Kolmannskog, Svein 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

One hundred fifty-three children with ALL were diagnosed in Norway in the period August 1975-December 1980. One hundred ond remission. thirty-two of them received 3 infusions of methotrexate as consolidation therapy combined with methotrexate intrathecally as CNS prophylaxis. Eleven (44%) of the tot

Infections in children with acute leukem

Infections in children with acute leukemia

✍ Freeman, Arnold I. ;Pantazopoulos, Nicholas ;Decastro, Leticia ;Sinks, Lucius F. 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

## Abstract Twenty children with ALL that died in 1959—1960 and 59 children with ALL that died in 1969 — 1970 were analyzed according to the infections at both their terminal illness and their initial presentations. Despite the availability of more effective agents for pseudomonas and staphylococcu

Systemic clearance of methotrexate in th

Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in children

✍ Joseph D. Borsi; Peter Johan Moe 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

The prognostic value of systemic clearance of methotrexate (MTX) has been evaluated in 58 children with acute lymphoblastic leukemia, receiving altogether 380 MTX infusions in a dose range of 0.5 to 33.6 g/mZ. The linear regression analysis of dose-steady state concentration relationship revealed th

Intermittent chemotherapy and bcg in con

Intermittent chemotherapy and bcg in continuation therapy of children with acute lymphocytic leukemia

✍ Ekert, Henry ;Jose, David G. ;Waters, Keith D. ;Smith, Peter J. ;Matthews, Rae N 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

## Abstract Continuation therapy using intermittent chemotherapy and BCG inoculation was commenced in 28 children with acute lymphocytic leukemia (ALL) immediately after remission induction and “CNS prophylaxis.” At a median followup time of 17 months, 71% remain in total remission and 86% in bone